title: Atypical posterior reversible encephalopathy syndrome associated with chemotherapy with Bevacizumab, Gemcitabine and Cisplatin.
authors: R
authors: R
authors: Dersch
authors: O
authors: O
authors: Stich
authors: K
authors: K
authors: Goller
authors: S
authors: S
authors: Meckel
authors: F
authors: F
authors: Dechent
authors: S
authors: S
authors: Doostkam
authors: C
authors: C
authors: Weiller
authors: J
authors: J
authors: Bardutzky
mesh_terms: D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001921:Brain / Q000473:pathology; D002945:Cisplatin / Q000627:therapeutic use; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D054038:Posterior Leukoencephalopathy Syndrome / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D003841:Deoxycytidine; D000068258:Bevacizumab; D002945:Cisplatin; D000093542:Gemcitabine